Facilitating Access to Approved Medication
Get Access To Fulvestrant Injection 250 mg
Fulvestrant was approved for medical use in the United States in 2002.
Fulvestrant Injection
- Generic Brand Name – Fulvestrant
- Innovator Brand Name – On Request
- API – Fulvestrant
- Packaging – 2×5ml
- Strength – 250mg/5ml
- Manufacturer Name – Samarth life science
What is fulvestrant and what it is used for?
Fulvestrant is an estrogen receptor antagonist used for the treatment of:
- HR +Ve metastatic breast cancer in the postmenopausal women with disease progression.
- HR +Ve, HER2 -Ve advanced breast cancer along with palbocilib in women with disease progression after the therapy of endocrine.
Disclaimer
All Trademarks and Brands that appear on website belong to their respective owners and Ikris Pharma Network does not lay and claim on them we only provide Information. We are NOT ONLINE store and We do not sell Narcotics and Sedatives. Iron Sucrose is a pharmaceutical drug that legally requires a medical prescription to be dispensed. Following Information meant for Wholesalers, Suppliers, Exporters, Doctors, Comparator Supplies, Hospitals, Generic, Brand, Corporate Sourcing, reseller, and Pharmacies.
Get Access To Fulvestrant Injection 250 mg
Shreyaansh Lifesciences, Jaipur. India
Shreyaansh Lifesciences is registered in Jaipur, India. Registration Number : 08AEEFS9350K1ZI under GST Act.
Branch Offices in India : Jaipur | New Delhi
SF-72-73 2ND FLOOR, Jaipur Electronic Market, Ridhi Sidhi Choraha, Jaipur, Rajasthan, 302018.
+91 99292 77766
Facts of Medicines
HOW SUPPLIED/STORAGE AND HANDLING:
Care should be exercised in the handling of FASLODEX. FASLODEX Injections should not be opened or broken. Refrigerate, 2°C to 8°C (36°F to 46°F). In order to protect from the light, store in the original carton until the time of use.
SIDE EFFECTS
Most common adverse reactions include bone pain, hot flash, musculoskeletal pain, nausea, arthralgia, injection site pain, headache, pain in extremity, cough, vomiting, constipation, back pain, fatigue, anorexia, asthenia, and dyspnea.
DOSAGE
The recommended fulvestrant dose is 500 mg, should be administered intramuscularly into the buttocks slowly (1 to 2 minutes per injection) as two 5 mL injections, one in each buttock, on the days 1’st, 15’th, 29’th and once monthly thereafter.
WARNINGS AND PRECAUTIONS
- The fulvestrant uses are normally contraindicated in patients with the known hypersensitivity to it or any of its existing components.
- The faslodex 250 injection should be used with caution in patients with thrombocytopenia, bleeding diathesis, or anticoagulant use.
- Caution should be imposed while administering faslodex at the dorsogluteal injection site due to the proximity of the underlying sciatic nerve.
- A fulvestrant 250 mg dose is recommended in patients with the moderate hepatic impairment.
- Women must be apprised of the potential hazard to the fetus and to avoid becoming pregnant while on Faslodex.
- Breastfeeding is restricted while on the therapy with fulvestrant 250 mg.
FAQs – Medicine Questions
From which class of drug Fulvestrant belongs?
What are the alternate brands of Fulvestrant Injection?
What are commonly reported side effects of Fulvestrant?
Where can I buy Fulvestrant injection?
You can buy Fulvestrant injection from any authorized whole-seller after getting a prescription from a qualified doctor. It is always better to check the credential of the whole-seller/supplier/exporter before buying the product.
The buyer should check the existing law in their home country before importing the product.
What is the procedure to buy Fulvestrant?
Patients can simply fill the order form or can send mail at info@treatmentoptions4u.com. Patients can also send WhatsApp messages to +91 98738 10020. We will reply ASAP with the details of the Fulvestrant Injection price as well as procurement procedure.
Note:- The order will be confirmed only after the receipt of the Valid prescription of the Clinician.
How should Fulvestrant be administered?
NEWS / UPDATES
- KD Tripathi, Essentials of Medical Pharmacology, Estrogens, Progestins and Contraceptives, 7th edition, 2013, 313.
- Goodman & Gilman’s, The Pharmacological Basics of Therapeutics, Estrogens and progestins, 12th edition, 2011, 1177.
- AstraZeneca, Electronic medicines compendium (emc), [ Revised on Dec 2020] [ Accessed on 15th April], https://www.medicines.org.uk/emc/files/pil.68.pdf
- AstraZeneca, US Food and Drug Administration, [ Revised on July 2011] [ Accessed on 15th April 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/021344s015lbl.pdf